Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia: update of an ongoing trial.
D000380:Agranulocytosis / Q000150:complications / Q000188:drug therapy*; D001424:Bacterial Infections / Q000150:complications; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005334:Fever / Q000150:complications; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D008094:Lithium / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy; D013921:Thrombocytopenia / Q000188:drug therapy; D013997:Time Factors
D003561:Cytarabine; D008094:Lithium; D003630:Daunorubicin